Due to the COVID-19 pandemic, the global Medical Tartaric Acid market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2023-2030. Fully considering the economic change by this health crisis, the Europe Medical Tartaric Acid market is estimated at US$ million in 2023, while the United States and China are forecast to reach US$ million and US$ million by 2030, respectively. The proportion of the United States is % in 2023, while Chinese percentage is %, and it is predicted that China market share will reach % in 2030, trailing a CAGR of % through the analysis period. As for the Europe Medical Tartaric Acid landscape, Germany is projected to reach US$ million by 2030. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Organic Synthesis accounting for % of the Medical Tartaric Acid global market in 2022, is projected to value US$ million by 2030, growing at a revised % CAGR from 2023 to 2030. While Drug Industrial Raw Materials segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2030.

The global major manufacturers of Medical Tartaric Acid include Giovanni Randi S.P.A. Randi Group, Boehringer-Ingelheim, Hangzhou Bao Jing Biochemical Co., LTD, Chang Mao Biochemistry Engineering Co., LTD, SYNFINE, CARBOMER, Wonda Science, CAMBREX and Labseeker Inc, etc. In terms of revenue, the global 3 largest players have a % market share of Medical Tartaric Acid in 2022.

 

This report focuses on Medical Tartaric Acid volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Medical Tartaric Acid market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

 

Global Medical Tartaric Acid Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

 

Segment by Type

 

  • Organic Synthesis
  • Artificially Synthesized

 

Segment by Application

 

  • Drug Industrial Raw Materials
  • Chiral Catalyst
  • Synthesis of Complex Natural Product Molecules
  • Antioxidant
  • Deoxidant

 

By Region

 

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

 

By Company

 

  • Giovanni Randi S.P.A. Randi Group
  • Boehringer-Ingelheim
  • Hangzhou Bao Jing Biochemical Co., LTD
  • Chang Mao Biochemistry Engineering Co., LTD
  • SYNFINE
  • CARBOMER
  • Wonda Science
  • CAMBREX
  • Labseeker Inc
  • GARAN S.K
  • AlliChem, LLC


CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414